期刊论文详细信息
Allergy, Asthma & Clinical Immunology
Clinical Management of Adult Patients with a History of Nonsteroidal Anti-Inflammatory Drug-Induced Urticaria/Angioedema: Update
Riccardo Asero1 
[1]Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano (MI), Italy
关键词: urticaria;    nonsteroidal anti-inflammatory drug;    drug allergy;    aspirin;   
Others  :  1083829
DOI  :  10.1186/1710-1492-3-1-24
PDF
【 授权许可】

   
2007 Canadian Society of Allergy and Clinical Immunology

【 预 览 】
附件列表
Files Size Format View
20150113112915444.pdf 191KB PDF download
【 参考文献 】
  • [1]Adkinson NF: Drug allergy. In Allergy: principles and practice. 5th edition. Edited by Middleton E, Reed CE, Ellis EF, et al. St Louis: CV Mosby; 1998:1212-24.
  • [2]Settipane GA: Aspirin and allergic diseases. Am J Med 1983, 74:102-10.
  • [3]Strom BL, Carson JL, Lee Morse M, et al.: The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1987, 30:1142-8.
  • [4]Settipane RA, Constantine HP, Settipane GA: Aspirin intolerance and recurrent urticaria in normal adults and children. Allergy 1980, 35:149-54.
  • [5]Mathison DA, Lumry WS, Stevenson DD, Curd JG: Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitisation [abstract]. J Allergy Clin Immunol 1982, (69 Suppl):135.
  • [6]Stevenson DD, Simon RA: Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In Allergy: principles and practice. 4th edition. Edited by Middleton E, Reed CE, Ellis EF, et al. St Louis: CV Mosby; 1993:1747-65.
  • [7]Stevenson DD, Simon RA: Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In Allergy: principles and practice. 5th edition. Edited by Middleton E, Reed CE, Ellis EF, et al. St Louis: CV Mosby; 1998:1225-34.
  • [8]Szczeklik A: Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1987, 57:113-8.
  • [9]Papa G, Romano A, Del Bono A, et al.: Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 1997, 78:74-8.
  • [10]Pastorello E, Zara C, Riario-Sforza GG, et al.: Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy 1998, 53:880-4.
  • [11]Quaratino D, Romano A, Papa G, et al.: Long-term tolerability of nimesulide and acetaminophen in nonsteroidal anti-inflammatory drug-intolerant patients. Ann Allergy Asthma Immunol 1997, 79:47-50.
  • [12]Quiralte J, Blanco C, Castillo R, et al.: Intolerance to nonsteroidal anti-inflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996, 98:678-85.
  • [13]Sanchez-Borges M, Capriles-Hulett A: Atopy is a risk factor for nonsteroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000, 84:101-6.
  • [14]Asero R: Detection of aspirin reactivity in patients with pyrazolones-induced skin disorders. Allergy 1998, 53:214-5.
  • [15]Asero R: Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Ann Allergy Asthma Immunol 1999, 82:554-8.
  • [16]Asero R: Multiple sensitivity to NSAID. Allergy 2000, 55:893-4.
  • [17]Carmona MJ, Blanca M, Garcia A, et al.: Intolerance to piroxicam in patients with adverse reactions to nonsteridal anti-inflammatory drugs. J Allergy Clin Immunol 1992, 90:873-9.
  • [18]Andri L, Senna G, Betteli C, et al.: Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy 1994, 72:29-32.
  • [19]Ispano M, Fontana A, Scibilia J, Ortolani C: Oral challenge with alternative nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. Drugs 1993, (46 Suppl):253-6.
  • [20]Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F, Perez CR: Tolerability to new COX-2 inhibitors in NSAIDsensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001, 87:201-4.
  • [21]Asero R: Tolerability of rofecoxib. Allergy 2001, 56:916-7.
  • [22]Nettis E, Di Paola R, Ferrannini A, Tursi A: Tolerability of rofecoxib in patients with cutaneous adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002, 88:331-4.
  • [23]Pacor ML, Di Lorenzo G, Biasi D, et al.: Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or nonsteroidal anti-inflammatory drugs. Clin Exp Allergy 2002, 32:397-400.
  • [24]Nettis E, Di Paola R, Ferrannini A, et al.: Meloxicam in hypersensitivity to NSAIDs. Allergy 2001, 56:803-4.
  • [25]Asero R: Chronic urticaria with multiple NSAID intolerance: is tramadol always a safe alternative analgesic? J Invest Allergol Clin Immunol 2003, 13:55-8.
  • [26]Maxwell DL, Atkinson BA, Spur BW, et al.: Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjects. J Allergy Clin Immunol 1990, 86:759-65.
  • [27]Mastalerz L, Setkowicz M, Sanak M, Szczeklik A: Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004, 113:771-5.
  • [28]Mastalerz L, Setkowicz M, Szczeklik A: Mechanism of chronic urticaria exacerbation by aspirin. Curr Allergy Asthma Rep 2005, 5:277-83.
  • [29]Asero R: Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann Allergy Asthma Immunol 2000, 85:156-7.
  • [30]Perez C, Sanchez-Borges M, Capriles E: Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J Allergy Clin Immunol 2001, 108:1060-1.
  • [31]Czerniawska-Mysik G, Szczeklik A: Idiosyncrasy to pyrazolone drugs. Allergy 1981, 36:381-4.
  • [32]Quiralte J, Blanco C, Castillo R, et al.: Anaphylactoid reactions due to nonsteroidal anti-inflammatory drugs: clinical and cross-reactivity studies. Ann Allergy Asthma Immunol 1997, 78:293-6.
  • [33]Ownby DR: Acetaminophen-induced urticaria and tolerance of ibuprofen in an eight-year-old child. J Allergy Clin Immunol 1997, 99:151-2.
  • [34]Vidal C, Perez-Carral C, Gonzalez-Quintela A: Paracetamol (acetaminophen) hypersensitivity. Ann Allergy Asthma Immunol 1997, 79:320-1.
  • [35]Mendizabal SL, Diez-Gomez ML: Paracetamol sensitivity without aspirin intolerance. Allergy 1998, 53:457-8.
  • [36]Kivity S, Pawlik I, Katz J: Acetaminophen hypersensitivity. Allergy 1999, 54:187-8.
  • [37]De Paramo BJ, Gancedo SQ, Cuevas M, et al.: Paracetamol (acetaminophen) hypersensitivity. Ann Allergy Asthma Immunol 2000, 85:508-11.
  • [38]Grant JA, Weiler JM: A report of a rare immediate reaction after ingestion of acetaminophen. Ann Allergy Asthma Immunol 2001, 87:227-9.
  • [39]Blanca M, Perez E, Garcia JJ, et al.: Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989, 62:295-8.
  • [40]Scala E, Giani M, Pirrotta L, et al.: Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal anti-inflammatory drug intolerance. J Allergy Clin Immunol 2001, 107:557.
  • [41]Asero R: Aspirin and paracetamol tolerance in patients with nimesulide-induced urticaria. Ann Allergy Asthma Immunol 1998, 82:237-8.
  • [42]Levy MB, Fink JN: Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 2001, 87:72-3.
  • [43]Grob M, Pichler WJ, Wuthrich B: Anaphylaxis to celecoxib. Allergy 2002, 57:264-5.
  • [44]Quiralte J, Sanchez-Garcia F, Torres MJ, et al.: Association of HLA-DR11 with the anaphylactoid reaction caused by nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1999, 103:685-9.
  • [45]Asero R: Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003, 111:1095-8.
  • [46]Stevenson DD, Sanchez-Borges M, Szczeklik A: Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclo-oxygenase enzymes [editorial]. Ann Allergy Asthma Immunol 2001, 87:1-4.
  • [47]Stevenson DD, Simon RA, Zuraw BL: Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In Allergy: principles and practice. 6th edition. Edited by Adkinson NF, Yunginger JW, Busse WW, et al. St Louis: CV Mosby; 2003:1695-710.
  • [48]Asero R, Tedeschi A, Lorini M: Autoreactivity is highly prevalent in patients with multiple intolerances to NSAID. Ann Allergy Asthma Immunol 2002, 88:468-72.
  • [49]Sabroe RA, Grattan CE, Francis DM, et al.: The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999, 140:446-52.
  • [50]Mukerjee D, Nissen SE, Topol EJ: Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001, 286:954-9.
  • [51]Asero R: Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. Clin Exp Allergy 2005, 35:713-6.
  • [52]Asero R: Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria. Ann Allergy Asthma Immunol 2006, 97:187-9.
  • [53]Warner TD, Giuliano F, Vojnovic I, et al.: Nonsteroid drug selectivities for cyclo-oxygenase 1 rather than cyclo-oxygenase 2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 1999, 96:7563-8.
  • [54]Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F: NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol 2002, 3:599-607.
  • [55]Cormican LJ, Farooque S, Altmann DR, Lee TH: Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity. Clin Exp Allergy 2005, 35:717-22.
  文献评价指标  
  下载次数:4次 浏览次数:6次